ABSTRACT
Background Early gut microbiota disruptions can increase the risk for dysbiosis and predispose to chronic diseases. While chlorinated drinking water is generally considered safe, the antimicrobial effects of chlorine-based disinfectants may negatively impact the developing infant microbiota, which is particularly vulnerable during this critical period. This study investigates the specific effects of chlorinated water on the gut microbiome in infants.
Methods The waTer qUality and Microbiome Study (TUMS) is a double-blinded, randomized controlled trial (RCT). Six-month old infants (n=197) received either de-chlorinated drinking water (via benchtop filtration), or regular tap water for twelve months. Stool samples were collected at six-months (baseline) and at eighteen-months of age. Metagenomic sequencing was used for faecal microbiome analysis. Samples of participant tap water was also collected pre- and post-intervention.
Results Participants were balanced for sex, delivery method, and breast-feeding status at time of recruitment between the control (n=98) and treatment (n=99) groups. We collected a total of 170 baseline stool samples (83 in the control group and 87 in the treatment group), and 130 follow-up stool samples (65 in the control group and 65 in the treatment group). Interindividual variation was higher at six-months compared to eighteen months. No significant differences in overall community structure (beta diversity (p=0.35), richness (p=0.98) or Shannon Index (p=0.45)) were found between treatment groups. However, 55 genera were differentially abundant at follow-up (adjusted p-value < 0.01), primarily within the Firmicutes phylum. Analysis of metabolic pathways revealed the chlorinated water group showed significantly higher abundance of antibiotic resistance genes mostly attributable to Escherichia and Klebsiella species.
Conclusion Water chlorination induces predominantly minor changes in infant gut microbiome composition; but appears to increase the abundance of antibiotic-resistant genes. While water chlorination remains a vital public health tool for ensuring safe drinking water, our findings underscore the need for continued research into the potential for increased antibiotic resistance and suggest there may be value in exploring alternative disinfectant strategies.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ACTRN12619000458134
Funding Statement
This work was supported by Telethon Kids Institute Blue Sky award 2018. Individual authors are supported by: DM work was supported by the Western Australian Future Health Research and Innovation Fund, which is an initiative of the WA State Government. VV work was supported by the funding endowed by the Family Larsson-Rosenquist Foundation. DJP was supported by the NHMRC Medical Research Futures Fund (MRFF) Career Development Fellowship ID1144544 (2018-2021) and the Telethon Kids Institute Ascend Fellowship (2022-2026).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the Ramsay Health Care (RHC) WA | SA Human Research Ethics Committee (EC00266; HREC reference number 1911). Mothers provided written informed consent on behalf of their children. All procedures were conducted in accordance with the Declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Australian New Zealand Clinical Trial Registry: ACTRN12619000458134, registered 20/03/2019, https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377164&isReview=true
DATA AVAILABILITY STATEMENT
Raw data supporting the conclusions of the article will be make available by the authors upon request.
